Sudden Infant Death Syndrome and Escalating Mortality
Sudden infant death syndrome (SIDS) is the leading cause of post-neonatal infant mortality in the U.S. By definition, SIDS describes death that occurs in a “seemingly normal, healthy infant under one year of age” that is both unexpected and unexplainable—although there is mounting evidence that SIDS may be “medically induced” through vaccination. One study from the Journal of Pediatrics revealed to the “complicated” and “convoluted” process involved in registering death for public purposes, finding gross inaccuracies and underreporting due to the inadequacies of death certificates as a source of complete information.
The United States has poorer child health outcomes than other wealthy nations despite greater per capita spending on health care for children.
U.S.-born children are 76% more likely to die before their first birthday than infants in the other wealthy countries.
For the first time since the 1990s, Americans are dying at a faster rate, and they’re dying younger. A pair of new studies suggest Americans are sicker than people in other rich countries, and in some states, progress on stemming the tide of basic diseases like diabetes has stalled or even reversed.
The Back to Sleep Campaign was initiated in 1994 to implement the American Academy of Pediatrics’ (AAP) recommendation that infants be placed in the nonprone sleeping position to reduce the risk of the Sudden Infant Death Syndrome (SIDS). This paper offers a challenge to the Back to Sleep Campaign (BTSC) from two perspectives: (1) the questionable validity of SIDS mortality and risk statistics, and (2) the BTSC as human experimentation rather than as confirmed preventive therapy.